Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

cDermo-1 causes dense skin, feathers, and scales in chickens.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

OR2AT4 helps reduce aging and cell damage in human skin cells.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

A 4kb fragment of the desmocollin 3 promoter targets gene expression to specific skin and hair follicle areas.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

PLDζ2 and NPC4 have different roles in lipid changes and root hair growth in Arabidopsis under low phosphate, with PLDζ2 reducing root hair growth and NPC4 promoting it.

AtCSLD3 and GhCSLD3 genes enhance root growth and cell elongation in plants.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

Disrupting a specific protein's function in hair follicle stem cells triggers their activation and a self-healing process.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

The scaffold improves wound healing and tissue regeneration.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

A specific gene change is linked to severe hair loss.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.